Clinical Trials Directory

Trials / Completed

CompletedNCT03202043

The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake

Sensitivity of Skin Carotenoid Status to Detect Changes in Intake of Varying Levels of Vegetables

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
USDA Grand Forks Human Nutrition Research Center · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study is designed to see if drinking a tomato-based vegetable juice will increase skin carotenoids.

Detailed description

The US Dietary Guidelines for Americans recommends that individuals consume approximately 2-4 c of vegetables each day to reduce risk of chronic disease, but current methods for assessing intake are either inaccurate (self-report) or invasive (blood carotenoid levels). Recent research indicates that skin carotenoid status may be a useful biomarker of vegetable intake, but the sensitivity to dose in unknown. In this study, we propose to test the dose-response of skin carotenoids to consumption of 3 different levels of vegetable juice (with a control group receiving water). We will test skin carotenoids in two ways: using resonance Raman spectroscopy (RRS), which we have previously validated, and with a new technique, pressure mediated reflection spectroscopy (RS; the "Veggie Meter"). We will compare the two techniques during an 8-week provided tomato-based juice intervention. Skin carotenoid readings will be compared to blood carotenoid concentrations and single nucleotide polymorphisms (SNPs) of genes related to the uptake, transport, and metabolism of carotenoids will be examined in blood and saliva.

Conditions

Interventions

TypeNameDescription
OTHERHigh dose vegetable juiceHigh dose (13 fl oz) vegetable juice
OTHERMedium dose vegetable juiceMedium dose (10 fl oz) vegetable juice
OTHERLow dose vegetable juiceLow dose (5.5 fl oz) vegetable juice
OTHERControl bottled waterControl (12 fl oz) bottled water

Timeline

Start date
2018-04-06
Primary completion
2019-05-21
Completion
2019-05-21
First posted
2017-06-28
Last updated
2022-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03202043. Inclusion in this directory is not an endorsement.